Blaney Davidson Esmeralda N, Vitters Elly L, van Lent Peter L E M, van de Loo Fons A J, van den Berg Wim B, van der Kraan Peter M
Experimental Rheumatology and Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Geert Grooteplein 26-28, Nijmegen, 6500 HB, The Netherlands.
Arthritis Res Ther. 2007;9(5):R102. doi: 10.1186/ar2305.
Bone morphogenetic protein-2 (BMP-2) has been proposed as a tool for cartilage repair and as a stimulant of chondrogenesis. In healthy cartilage, BMP-2 is hardly present, whereas it is highly expressed during osteoarthritis. To assess its function in cartilage, BMP-2 was overexpressed in healthy murine knee joints and the effects on proteoglycan (PG) synthesis and degradation were evaluated. Moreover, the contribution of BMP in repairing damage induced by interleukin-1 (IL-1) was investigated. Ad-BMP-2 was injected intra-articularly into murine knee joints, which were isolated 3, 7, and 21 days after injection for histology, immunohistochemistry, and autoradiography. In addition, patellar and tibial cartilage was isolated for RNA isolation or measurement of PG synthesis by means of 35SO4(2-) incorporation. To investigate the role for BMP-2 in cartilage repair, cartilage damage was induced by intra-articular injection of IL-1. After 2 days, Ad-BMP-2, Ad-BMP-2 + Ad-gremlin, Ad-gremlin, or a control virus was injected. Whole knee joints were isolated for histology at day 4 or patellae were isolated to measure 35SO4(2-) incorporation. BMP-2 stimulated PG synthesis in patellar cartilage on all days and in tibial cartilage on day 21. Aggrecan mRNA expression had increased on all days in patellar cartilage, with the highest increase on day 7. Collagen type II expression showed a similar expression pattern. In tibial cartilage, collagen type II and aggrecan mRNA expression had increased on days 7 and 21. BMP-2 overexpression also induced increased aggrecan degradation in cartilage. VDIPEN staining (indicating matrix metalloproteinase activity) was elevated on day 3 in tibial cartilage and on days 3 and 7 in patellar cartilage, but no longer was by day 21. Increased NITEGE staining (indicating aggrecanase activity) was found on days 7 and 21. In IL-1-damaged patellar cartilage, BMP-2 boosted PG synthesis. Blocking of BMP activity resulted in a decreased PG synthesis compared with IL-1 alone. This decreased PG synthesis was associated with PG depletion in the cartilage. These data show that BMP-2 boosts matrix turnover in intact and IL-damaged cartilage. Moreover, BMP contributes to the intrinsic repair capacity of damaged cartilage. Increased matrix turnover might be functional in replacing matrix molecules in the repair of a damaged cartilage matrix.
骨形态发生蛋白-2(BMP-2)已被提议作为软骨修复的工具和软骨生成的刺激物。在健康软骨中,BMP-2几乎不存在,而在骨关节炎期间其表达高度上调。为了评估其在软骨中的功能,在健康小鼠膝关节中过表达BMP-2,并评估其对蛋白聚糖(PG)合成和降解的影响。此外,还研究了BMP在修复白细胞介素-1(IL-1)诱导的损伤中的作用。将腺病毒载体BMP-2(Ad-BMP-2)关节腔内注射到小鼠膝关节中,在注射后3、7和21天分离膝关节进行组织学、免疫组织化学和放射自显影检查。此外,分离髌软骨和胫骨软骨用于RNA提取或通过35SO4(2-)掺入法测量PG合成。为了研究BMP-2在软骨修复中的作用,通过关节腔内注射IL-1诱导软骨损伤。2天后,注射Ad-BMP-2、Ad-BMP-2 + Ad- gremlin、Ad- gremlin或对照病毒。在第4天分离全膝关节进行组织学检查,或分离髌骨测量35SO4(2-)掺入情况。BMP-2在所有时间点均刺激髌软骨中的PG合成,在第21天刺激胫骨软骨中的PG合成。髌软骨中聚集蛋白聚糖mRNA表达在所有时间点均增加,第7天增加最为明显。II型胶原蛋白表达呈现类似的表达模式。在胫骨软骨中,II型胶原蛋白和聚集蛋白聚糖mRNA表达在第7天和第21天增加。BMP-2过表达还诱导软骨中聚集蛋白聚糖降解增加。胫骨软骨在第3天、髌软骨在第3天和第7天的VDIPEN染色(表明基质金属蛋白酶活性)升高,但在第21天不再升高。在第7天和第21天发现NITEGE染色增加(表明聚集蛋白聚糖酶活性)。在IL-1损伤的髌软骨中,BMP-2促进PG合成。与单独使用IL-1相比,阻断BMP活性导致PG合成减少。这种PG合成减少与软骨中PG消耗有关。这些数据表明,BMP-2促进完整和IL-1损伤软骨中的基质周转。此外,BMP有助于受损软骨的内在修复能力。增加的基质周转可能在修复受损软骨基质时替换基质分子方面发挥作用。